On a mission to help the population synchronise their circadian rhythm, Galventa, the Swiss life science startup behind the first nutraceutical supplement to control the wake-up process, has secured a CHF 750,000 seed investment led by the Turkish pharma firm Gen Ilac.
Galventa, which is currently part of the Founders Factory accelerator program, will use the capital to expand its team, product portfolio and scale up production of solutions utilising its innovative and clinically tested galenic platform technologies.
This includes the upcoming launch of its world-first nutraceutical product - B・SYNC ON - into European markets, such as Switzerland, Germany and the UK. Containing caffeine, vitamin B5 and B12 as well as Zinc to reduce tiredness and boost mental performance, B・SYNC ON is a delayed release wake-up supplement that helps people wake-up naturally after a full night’s sleep with sharper focus and a positive mood.
Commenting on the raise, Sascha Fritsche, CEO and Co-Founder, said: “This is a big milestone for Galventa. We are excited to see such great interest and trust in our innovative technology and our first nutraceutical product. After conducting first market tests we look forward to fully launching B・SYNC ON and helping the large population with wake-up difficulties.”
Galventa AG is a Swiss startup on a mission to help the population synchronise their circadian rhythm to improve sleep and waking-up through the development of innovative and clinically tested galenic platform technologies. The startup has developed a patentable solution based on micro-pellets that allows establishing time-controlled release systems containing an active substance. The first nutraceutical product (B・SYNC ON) is for those who seek to control their sleep-wake cycle and wake up with ease. It is the only clinically tested food supplement that empowers you to control your wake-up process.
As the world's leading venture studio and accelerator, Founders Factory builds and scales technology startups solving global problems.
Founded in 2015 by Brent Hoberman, Henry Lane Fox and George Northcott, Founders Factory combines capital and bespoke support from a team of over 100 specialists with a broad network of corporates and established entrepreneurs.
The Founders Factory portfolio includes over 200 category-defining tech companies globally, 45+ of which have been built from scratch in its Venture Studio. Their partners include Aviva, L’Oreal, Guardian Media Group, easyJet, Reckitt, Chinese private equity firm CSC Group and Standard Bank.
